Skip to main content
Clinical Trials/TCTR20200519002
TCTR20200519002CompletedPhase 1

The effectiveness of Nicergoline on prevention of acoustic trauma

Siam phamaceutical0 sites250 target enrollmentStarted: May 19, 2020Last updated:

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
250

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 25 Years (—)
Sex
Male

Inclusion Criteria

  • 1normal CBC,BUN,CR,electrolyte
  • 2normal audiogram
  • 3Thai male age between 18-25years old with no underlying

Exclusion Criteria

  • 1abnormal audiogram
  • 2abnormal lab
  • 3allergic to sulfa-drug

Investigators

Sponsor
Siam phamaceutical

Similar Trials